• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:2014年修订版]

[ESC/EACTS guidelines on myocardial revascularization : Amendments 2014].

作者信息

Nef H, Renker M, Hamm C W

机构信息

Medizinische Klinik I, Kardiologie und Angiologie, Universitätsklinikum Gießen, Klinikstr. 33, 35392, Gießen, Deutschland,

出版信息

Herz. 2014 Dec;39(8):913-8. doi: 10.1007/s00059-014-4180-4.

DOI:10.1007/s00059-014-4180-4
PMID:25406330
Abstract

One of the most important treatment principles in interventional cardiology relies on myocardial revascularization by percutaneous coronary intervention (PCI) or surgical placement of coronary artery bypass grafts (CABG). However, in order to apply these principles effectively, it is important to identify patients who require revascularization. Consequently, the appropriate method has to be selected to effectively restore blood flow. Patients will only benefit from the interventional or surgical procedures when those revascularization measures that can cause more harm than good are avoided. In the new European Society of Cardiology and European Association for Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization some new aspects will be addressed.

摘要

介入心脏病学中最重要的治疗原则之一是通过经皮冠状动脉介入治疗(PCI)或冠状动脉旁路移植术(CABG)进行手术来实现心肌血运重建。然而,为了有效应用这些原则,识别需要血运重建的患者很重要。因此,必须选择合适的方法来有效恢复血流。只有避免那些弊大于利的血运重建措施,患者才能从介入或外科手术中获益。在欧洲心脏病学会和欧洲心胸外科学会(ESC/EACTS)关于心肌血运重建的新指南中,将探讨一些新的方面。

相似文献

1
[ESC/EACTS guidelines on myocardial revascularization : Amendments 2014].[欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:2014年修订版]
Herz. 2014 Dec;39(8):913-8. doi: 10.1007/s00059-014-4180-4.
2
Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.欧洲心脏病学会和欧洲心胸外科学会指南对稳定型冠状动脉疾病血运重建策略的影响:经皮冠状动脉介入治疗和冠状动脉旁路移植术的活动变化。
J Thorac Cardiovasc Surg. 2014 Feb;147(2):606-10. doi: 10.1016/j.jtcvs.2013.01.026. Epub 2013 Feb 10.
3
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.2022 年 ESC/EACTS 联合对 2018 年指南建议的回顾:低手术风险且适合 PCI 或 CABG 解剖结构的左主干冠状动脉疾病患者的血运重建。
Eur J Cardiothorac Surg. 2023 Aug 1;64(2). doi: 10.1093/ejcts/ezad286.
4
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.2022 年 ESC/EACTS 联合对 2018 年指南建议的回顾:低手术风险且适合 PCI 或 CABG 解剖结构的左主干冠状动脉疾病患者的血运重建。
Eur Heart J. 2023 Nov 1;44(41):4310-4320. doi: 10.1093/eurheartj/ehad476.
5
Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading?2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南解读:血运重建五十年:我们身处何方,又将走向何处?
J Cardiovasc Transl Res. 2015 Jun;8(4):211-20. doi: 10.1007/s12265-015-9632-6. Epub 2015 May 19.
6
[ESC/EACTS guidelines on myocardial revascularization 2018 : The most important innovations].[2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:最重要的创新]
Herz. 2018 Dec;43(8):689-694. doi: 10.1007/s00059-018-4764-5.
7
[The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].[欧洲心脏病学会(ESC)经皮冠状动脉介入治疗(PCI)指南。三例病例报告]
Herz. 2006 Dec;31(9):836-46, 848. doi: 10.1007/s00059-006-2939-y.
8
Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.对于被归类为经皮冠状动脉介入治疗推荐等级为II级和III级的患者,在接受传统冠状动脉搭桥术治疗左主干病变后的长期预后及比较。
Eur J Cardiothorac Surg. 2014 Mar;45(3):431-7. doi: 10.1093/ejcts/ezt429. Epub 2013 Aug 26.
9
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014 欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组。由欧洲经皮心血管介入协会(EAPCI)提供特别贡献制定。
Eur J Cardiothorac Surg. 2014 Oct;46(4):517-92. doi: 10.1093/ejcts/ezu366. Epub 2014 Aug 29.
10
Discrepancy between the European clinical guidelines and myocardial revascularization in patients with stable coronary artery disease in Russia.俄罗斯稳定型冠状动脉疾病患者的欧洲临床指南与血运重建治疗之间的差异。
Int J Qual Health Care. 2019 May 1;31(4):269-275. doi: 10.1093/intqhc/mzy140.

引用本文的文献

1
Histone Deacetylase SIRT1, Smooth Muscle Cell Function, and Vascular Diseases.组蛋白去乙酰化酶SIRT1、平滑肌细胞功能与血管疾病
Front Pharmacol. 2020 Oct 6;11:537519. doi: 10.3389/fphar.2020.537519. eCollection 2020.
2
Instantaneous wave-free ratio (iFR) to determine hemodynamically significant coronary stenosis: A comprehensive review.用于确定血流动力学显著冠状动脉狭窄的瞬时无波比值(iFR):一项综述。
World J Cardiol. 2018 Dec 26;10(12):267-277. doi: 10.4330/wjc.v10.i12.267.
3
[Instantaneous wave-free ratio (iFR®) in patients with coronary artery disease].

本文引用的文献

1
Prehospital ticagrelor in ST-segment elevation myocardial infarction.院前替格瑞洛在 ST 段抬高型心肌梗死中的应用。
N Engl J Med. 2014 Sep 11;371(11):1016-27. doi: 10.1056/NEJMoa1407024. Epub 2014 Sep 1.
2
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组编写,欧洲经皮心血管介入协会(EAPCI)提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
3
冠心病患者的瞬时无波比率(iFR®)
Herz. 2018 Nov;43(7):621-627. doi: 10.1007/s00059-017-4608-8. Epub 2017 Aug 23.
4
[Computed tomography in patients with chronic stable angina : Fractional flow reserve measurement].[慢性稳定型心绞痛患者的计算机断层扫描:血流储备分数测量]
Herz. 2017 Feb;42(1):51-57. doi: 10.1007/s00059-016-4433-5. Epub 2016 Jun 2.
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.稳定性冠心病患者的血运重建与药物治疗:网状荟萃分析。
BMJ. 2014 Jun 23;348:g3859. doi: 10.1136/bmj.g3859.
4
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.在紫杉醇药物涂层支架与心脏搭桥术联合治疗左主干病变研究中,经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗左主干病变患者的 5 年结果。
Circulation. 2014 Jun 10;129(23):2388-94. doi: 10.1161/CIRCULATIONAHA.113.006689. Epub 2014 Apr 3.
5
Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.在植入 Resolute 佐他莫司洗脱支架 1 至 12 个月期间,双联抗血小板治疗的使用与支架血栓形成之间缺乏关联。
Eur Heart J. 2014 Aug 1;35(29):1949-56. doi: 10.1093/eurheartj/ehu026. Epub 2014 Feb 7.
6
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.载有佐他莫司的药物洗脱支架置入后双联抗血小板治疗 3 个月与 12 个月:OPTIMIZE 随机试验。
JAMA. 2013 Dec 18;310(23):2510-22. doi: 10.1001/jama.2013.282183.
7
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.2013年欧洲心脏病学会稳定型冠状动脉疾病管理指南:欧洲心脏病学会稳定型冠状动脉疾病管理特别工作组
Eur Heart J. 2013 Oct;34(38):2949-3003. doi: 10.1093/eurheartj/eht296. Epub 2013 Aug 30.
8
Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.非 ST 段抬高型急性冠状动脉综合征患者的普拉格雷预处理。
N Engl J Med. 2013 Sep 12;369(11):999-1010. doi: 10.1056/NEJMoa1308075. Epub 2013 Sep 1.
9
The occurrence of adverse events in relation to time after registration for coronary artery bypass surgery: a population-based observational study.冠状动脉搭桥手术后登记时间与不良事件的发生:一项基于人群的观察性研究。
J Cardiothorac Surg. 2013 Apr 11;8:74. doi: 10.1186/1749-8090-8-74.
10
Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study.替格瑞洛经救护车或导管室用于 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗:随机、双盲、替格瑞洛在救护车或导管室用于新出现 ST 段抬高型心肌梗死开通冠状动脉(ATLANTIC)研究的原理和设计。
Am Heart J. 2013 Apr;165(4):515-22. doi: 10.1016/j.ahj.2012.12.015. Epub 2013 Feb 13.